Castle Biosciences Valuation
| CSTL Stock | USD 27.48 0.05 0.18% |
At this time, the firm appears to be undervalued. Castle Biosciences shows a prevailing Real Value of $31.02 per share. The current price of the firm is $27.48. Our model approximates the value of Castle Biosciences from analyzing the firm fundamentals such as Return On Equity of 0.0147, current valuation of 516.6 M, and Profit Margin of 0.02 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Castle Biosciences' valuation include:
Price Book 1.745 | Enterprise Value 516.6 M | Enterprise Value Ebitda 20.5996 | Price Sales 2.4678 | Trailing PE 130.8572 |
Undervalued
Today
Please note that Castle Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Castle Biosciences is based on 3 months time horizon. Increasing Castle Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Castle stock is determined by what a typical buyer is willing to pay for full or partial control of Castle Biosciences. Since Castle Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Castle Stock. However, Castle Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.48 | Real 31.02 | Target 33.0 | Hype 27.46 |
The intrinsic value of Castle Biosciences' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Castle Biosciences' stock price.
Estimating the potential upside or downside of Castle Biosciences helps investors to forecast how Castle stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Castle Biosciences more accurately as focusing exclusively on Castle Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Castle Biosciences' intrinsic value based on its ongoing forecasts of Castle Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Castle Biosciences' closest peers.
Castle Biosciences Cash |
|
Castle Valuation Trend
Knowing Castle Biosciences' actual value is paramount for traders when making sound investment determinations. Using both Castle Biosciences' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Castle Biosciences Total Value Analysis
Castle Biosciences is currently anticipated to have valuation of 516.6 M with market capitalization of 769.64 M, debt of 15.34 M, and cash on hands of 273.17 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Castle Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
516.6 M | 769.64 M | 15.34 M | 273.17 M |
Castle Biosciences Investor Information
About 95.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.75. Some equities with similar Price to Book (P/B) outperform the market in the long run. Castle Biosciences had not issued any dividends in recent years. Based on the key indicators related to Castle Biosciences' liquidity, profitability, solvency, and operating efficiency, Castle Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Castle Biosciences Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Castle suggests not a very effective usage of assets in December.Castle Biosciences Ownership Allocation
Castle Biosciences holds a total of 28.01 Million outstanding shares. The majority of Castle Biosciences outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Castle Biosciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Castle Biosciences. Please pay attention to any change in the institutional holdings of Castle Biosciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Castle Biosciences Profitability Analysis
The company reported the previous year's revenue of 219.79 M. Net Loss for the year was (57.47 M) with profit before overhead, payroll, taxes, and interest of 105.03 M.About Castle Biosciences Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Castle Biosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Castle Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Castle Biosciences's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Castle Biosciences's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Castle Biosciences. We calculate exposure to Castle Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Castle Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 174.8 M | 183.5 M | |
| Pretax Profit Margin | (0.26) | (0.27) | |
| Operating Profit Margin | (0.31) | (0.32) | |
| Net Loss | (0.26) | (0.27) | |
| Gross Profit Margin | 0.80 | 0.63 |
Castle Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Castle Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 26.8 M | |
| Quarterly Earnings Growth Y O Y | -0.926 |
Castle Biosciences Current Valuation Indicators
Castle Biosciences' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Castle Biosciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Castle Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Castle Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Castle Biosciences' worth.When determining whether Castle Biosciences is a strong investment it is important to analyze Castle Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Castle Biosciences' future performance. For an informed investment choice regarding Castle Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share 0.21 | Revenue Per Share 11.34 | Quarterly Revenue Growth 0.395 | Return On Assets (0) |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.